5Toskes PP.Hyperlipidemic pancreatitis[J].Gastroenterol Clin North Am,1990,19(4):783-791.
6Yadav D,Pitchumoni CS.Issues in hyperlipidemic pancreatitis[J].J Clin Gastroenterol,2003,36(1):54-62.
7Blom DJ,Byrnes P,Jones S,et al.Dysbetalipoproteinaemia-clinical and pathophysiological features[J].S Afr MM J,2002,92(11):892-897.
8Hozumi Y,KawanoM,SaitoT,etal.Effect of tamoxifen on serum lipid metabolism[J].J Clin Endocrinol Metab,1998,83(5):1632-1635.
9Witko-Sarsat V, Friedlander M, Capeill6re-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in urcmia[J]. Kidney Int, 1996, 49(5): 1304-13.
10Piwowar A, Knapik-Kordecka M, Warwas M. AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes rnellitus[J] Diabetes Res Clin Pract, 2007, 77(2): 188-92.